Summary
Johnson & Johnson (JNJ) filed an 8-K on October 18, 2011, reporting its third-quarter financial results for the period ended October 2, 2011. The filing primarily consists of a press release and supplementary sales data, indicating the company's performance during the quarter. Investors would be looking to this report for key sales figures and earnings per share to assess the company's operational health and compare it against expectations and prior periods.
Key Highlights
- 1Johnson & Johnson announced its third-quarter 2011 financial results on October 18, 2011.
- 2The report pertains to the third quarter ended October 2, 2011.
- 3Key financial information was disseminated through an attached press release (Exhibit 99.15).
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the quarter were also provided (Exhibit 99.20).
- 5This 8-K serves as the primary disclosure vehicle for JNJ's Q3 2011 operational and financial performance.
- 6Investors can analyze the provided data to understand sales trends and profitability for the specified quarter.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide key financial information regarding Johnson & Johnson's (JNJ) third-quarter results for the period ended October 2, 2011. This includes sales and earnings data.
The filing includes a press release detailing the company's third-quarter sales and earnings, along with unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the quarter.
The detailed financial performance data for JNJ's third quarter of 2011 can be found in the attached Exhibits 99.15 (Press Release) and 99.20 (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings) to this 8-K filing.